Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance

ClinicalTrials.gov ID: NCT03597516

Public ClinicalTrials.gov record NCT03597516. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 6:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study conducted in the United States (US) to assess the efficacy of RP-G28 compared to placebo on symptom reduction related to lactose intolerance.

Study identification

NCT ID
NCT03597516
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ritter Pharmaceuticals, Inc.
Industry
Enrollment
557 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 26, 2018 (Actual)
Primary completion
Jul 2, 2019 (Actual)
Completion
Jul 2, 2019 (Actual)
Last update posted
Jul 8, 2019

2018 – 2019

United States locations

U.S. sites
35
U.S. states
19
U.S. cities
34
Facility City State ZIP Site status
Research Facility Birmingham Alabama 35205 —
Research Site Chula Vista California 91910 —
Research Site Huntington Park California 90255 —
Research Site Lincoln California 95648 —
Research Site Los Angeles California 90057 —
Research Site Panorama City California 91402 —
Research Site San Diego California 92114 —
Research Site San Diego California 92123 —
Research Site Walnut Creek California 94598 —
Research Site Colorado Springs Colorado 80906 —
Research Site Gainesville Florida 32653 —
Research Facility Miami Florida 33135 —
Research Site Orlando Florida 32806 —
Reseaarch Site Pompano Beach Florida 33060 —
Research Site Honolulu Hawaii 96815 —
Research Site Marrero Louisiana 70072 —
Research Site Oxon Hill Maryland 20745 —
Research Site Wyoming Michigan 49519 —
Research Site Omaha Nebraska 68114 —
Research Site Berlin New Jersey 08009 —
Research Site Albuquerque New Mexico 87102 —
Research Site Brooklyn New York 11230 —
Research Site Great Neck New York 11023 —
Research Site Hartsdale New York 10530 —
Research Site Raleigh North Carolina 27612 —
Research Site Cincinnati Ohio 45246 —
Research Site Dayton Ohio 45439 —
Research Site Charleston South Carolina 29406 —
Research Site Knoxville Tennessee 37909 —
Research Site Houston Texas 77099 —
Research Site Lampasas Texas 76550 —
Research Site San Antonio Texas 78209 —
Research Site Waxahachie Texas 75165 —
Research Site Fairfax Virginia 22031 —
Research Site Bellevue Washington 98004 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03597516, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2019 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03597516 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →